The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.

Name: The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus, type 2, kidney function tests

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 640526
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.